v3.22.1
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2020 $ 45 $ 433,941 $ 247,638 $ 14,087 $ 695,711
Beginning balance (in shares) at Dec. 31, 2020 44,667,650        
Net income     22,355   22,355
Other comprehensive income (loss)       (18) (18)
Stock based compensation   995     995
Cash dividend     (4,023)   (4,023)
Exercise of options   354     354
Exercise of options (in shares) 47,000        
Stock grants - vesting of restricted stock units (in shares) 108,085        
Repurchase of shares from restricted shares vesting   (944)     (944)
Repurchase of shares from restricted shares vesting (in shares) (40,580)        
Ending balance at Mar. 31, 2021 $ 45 434,346 265,970 14,069 714,430
Ending balance (in shares) at Mar. 31, 2021 44,782,155        
Beginning balance at Dec. 31, 2021 $ 56 720,744 340,976 2,275 1,064,051
Beginning balance (in shares) at Dec. 31, 2021 56,432,070        
Net income     30,836   30,836
Other comprehensive income (loss)       (6,207) (6,207)
Stock based compensation   1,204     1,204
Cash dividend     (6,208)   (6,208)
Exercise of options   18     18
Exercise of options (in shares) 2,000        
Stock grants - vesting of restricted stock units $ 1       1
Stock grants - vesting of restricted stock units (in shares) 122,700        
Repurchase of shares from restricted shares vesting   (1,120)     (1,120)
Repurchase of shares from restricted shares vesting (in shares) (42,602)        
Ending balance at Mar. 31, 2022 $ 57 $ 720,846 $ 365,604 $ (3,932) $ 1,082,575
Ending balance (in shares) at Mar. 31, 2022 56,514,168